Retraction notices

Xuebijing injection alleviates liver injury in patients with hepatocellular carcinoma by inhibiting inflammatory response after transarterial chemoembolization

Type
Retraction
Notice date
12/31/2021 0:00
Journal
Tropical Journal of Pharmaceutical Research
Publisher
Pharmacotherapy Group
Notice DOI
10.4314/tjpr.v20i12.31
Original paper DOI
10.4314/tjpr.v20i8.22

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.